InVivo Therapeutics Announces Oral Platform Presentation At 2016 Congress Of Neurological Surgeons Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that Nicholas Theodore, M.D., Director of the John Hopkins Neurosurgical Spine Center, will be giving an oral platform presentation titled “High AIS Grade Conversion Rate Following Neuro-Spinal Scaffold Implantation in Acute Thoracic Complete AIS A Spinal Cord Injury (SCI): Potential Mechanisms” at the 2016 Congress of Neurological Surgeons (CNS) Annual Meeting to be held September 24-28, 2016 in San Diego, CA. The presentation will be made on Tuesday, September 27, during the section on Neurotrauma and Critical Care.

MORE ON THIS TOPIC